| scholarly article | Q13442814 |
| P50 | author | Nicolas Cuenca | Q55727127 |
| Laura Fernández-Sánchez | Q60897303 | ||
| Sergio Esteban-Pérez | Q88146709 | ||
| Alicia Arranz-Romera | Q125202986 | ||
| Irene Bravo-Osuna | Q39518434 | ||
| Rocio Herrero-Vanrell | Q39518488 | ||
| P2093 | author name string | Isabel Pinilla | |
| Pedro Lax | |||
| Victoria Maneu | |||
| María Del Mar Puebla-González | |||
| P2860 | cites work | Impairment of intrinsically photosensitive retinal ganglion cells associated with late stages of retinal degeneration. | Q50908020 |
| Inherited Photoreceptor Degeneration Causes the Death of Melanopsin-Positive Retinal Ganglion Cells and Increases Their Coexpression of Brn3a. | Q53413778 | ||
| Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease. | Q54498834 | ||
| Clearance of sodium fluorescein incorporated into microspheres from the vitreous after intravitreal injection | Q70151929 | ||
| Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres | Q70216445 | ||
| Circadian dysfunction in P23H rhodopsin transgenic rats: effects of exogenous melatonin | Q82378752 | ||
| Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30 | Q24649167 | ||
| Bile acids in treatment of ocular disease | Q24653326 | ||
| Natural Compounds from Saffron and Bear Bile Prevent Vision Loss and Retinal Degeneration | Q26799250 | ||
| Safranal, a saffron constituent, attenuates retinal degeneration in P23H rats | Q27323948 | ||
| Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration | Q27330551 | ||
| RIBEYE, a component of synaptic ribbons: a protein's journey through evolution provides insight into synaptic ribbon function | Q28143542 | ||
| Identification and light-dependent translocation of a cone-specific antigen, cone arrestin, recognized by monoclonal antibody 7G6 | Q28181862 | ||
| Retinal degeneration mutants in the mouse | Q28202375 | ||
| RIBEYE, a Component of Synaptic Ribbons | Q29540824 | ||
| Retinitis pigmentosa | Q29616538 | ||
| Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa | Q30453882 | ||
| Ocular drug delivery | Q30475605 | ||
| Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres | Q33267927 | ||
| 'RetinoGenetics': a comprehensive mutation database for genes related to inherited retinal degeneration | Q33767318 | ||
| Safety evaluation of poly(lactic-co-glycolic acid)/poly(lactic-acid) microspheres through intravitreal injection in rabbits | Q33830339 | ||
| Pathophysilogical mechanism and treatment strategies for Leber congenital amaurosis | Q33842436 | ||
| Constituents of bile, bilirubin and TUDCA, protect against oxidative stress-induced retinal degeneration | Q33853136 | ||
| Calpain and PARP activation during photoreceptor cell death in P23H and S334ter rhodopsin mutant rats | Q33963936 | ||
| Tauroursodeoxycholic acid (TUDCA) protects photoreceptors from cell death after experimental retinal detachment | Q34035789 | ||
| Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. | Q34075502 | ||
| A point mutation of the rhodopsin gene in one form of retinitis pigmentosa | Q34168407 | ||
| Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats. | Q34179718 | ||
| Loss of outer retinal neurons and circuitry alterations in the DBA/2J mouse | Q34249889 | ||
| Distribution of vesicular glutamate transporters in rat and human retina. | Q34499607 | ||
| Neural remodeling in retinal degeneration. | Q35189368 | ||
| Expression and cellular localization of the voltage-gated calcium channel α2δ3 in the rodent retina. | Q35629974 | ||
| Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies | Q35684362 | ||
| Neuroprotective Effect of Tauroursodeoxycholic Acid on N-Methyl-D-Aspartate-Induced Retinal Ganglion Cell Degeneration. | Q35778523 | ||
| Drug delivery systems for vitreoretinal diseases | Q35792000 | ||
| TUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice | Q35797129 | ||
| Long time remodeling during retinal degeneration evaluated by optical coherence tomography, immunocytochemistry and fundus autofluorescence. | Q35828691 | ||
| Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease. | Q35861134 | ||
| Retinal remodeling during retinal degeneration. | Q36139526 | ||
| Proinsulin slows retinal degeneration and vision loss in the P23H rat model of retinitis pigmentosa | Q36469478 | ||
| Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation | Q37017458 | ||
| Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis | Q37257418 | ||
| Photoreceptor cell death mechanisms in inherited retinal degeneration. | Q37316717 | ||
| Tauroursodeoxycholic acid prevents E22Q Alzheimer's Abeta toxicity in human cerebral endothelial cells. | Q37384925 | ||
| Functional changes in inner retinal neurons in animal models of photoreceptor degeneration. | Q37711206 | ||
| Controlled transscleral drug delivery formulations to the eye: establishing new concepts and paradigms in ocular anti-inflammatory therapeutics and antibacterial prophylaxis | Q37774343 | ||
| Retinal remodeling. | Q38014324 | ||
| The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies. | Q38211153 | ||
| Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases. | Q38231191 | ||
| Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus. | Q38558972 | ||
| Biodegradation and tissue reaction to intravitreous biodegradable poly(D,L-lactic-co-glycolic)acid microspheres | Q38564886 | ||
| Novel biodegradable polyesteramide microspheres for controlled drug delivery in Ophthalmology. | Q38871711 | ||
| Late histological and functional changes in the P23H rat retina after photoreceptor loss | Q39144181 | ||
| Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure. | Q39518050 | ||
| Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma | Q40062586 | ||
| Apoptosis, retinitis pigmentosa, and degeneration | Q40470522 | ||
| Apoptotic cell death in retinal degenerations. | Q40839433 | ||
| Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa | Q41467175 | ||
| Microglia activation in a model of retinal degeneration and TUDCA neuroprotective effects | Q41814116 | ||
| Chemical chaperone TUDCA preserves cone photoreceptors in a mouse model of Leber congenital amaurosis | Q41824260 | ||
| Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier | Q42153590 | ||
| Retinal ganglion cell numbers and delayed retinal ganglion cell death in the P23H rat retina | Q42855462 | ||
| Biodegradable microspheres for vitreoretinal drug delivery | Q43774516 | ||
| Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease. | Q44035977 | ||
| A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system | Q44045954 | ||
| Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration | Q44705768 | ||
| Regressive and reactive changes in the connectivity patterns of rod and cone pathways of P23H transgenic rat retina. | Q44985297 | ||
| Enhanced cone dysfunction in rats homozygous for the P23H rhodopsin mutation | Q46505120 | ||
| Tauroursodeoxycholic acid protects retinal neural cells from cell death induced by prolonged exposure to elevated glucose | Q46518646 | ||
| Tauroursodeoxycholic Acid Protects Retinal Function and Structure in rd1 Mice | Q46661023 | ||
| Activation of multiple pathways during photoreceptor apoptosis in the rd mouse. | Q46722401 | ||
| Tool from ancient pharmacopoeia prevents vision loss. | Q47818770 | ||
| Macromolecules released from polymers: diffusion into unstirred fluids | Q48872061 | ||
| P23H rhodopsin transgenic rat: correlation of retinal function with histopathology | Q49055707 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vision loss | Q507787 |
| biodegradation | Q696715 | ||
| microsphere | Q1759020 | ||
| retinal degeneration | Q3043268 | ||
| biodegradable microsphere | Q125660129 | ||
| P304 | page(s) | e0177998 | |
| P577 | publication date | 2017-05-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats | |
| P478 | volume | 12 |
| Q64916422 | 3D printed poly(ε-caprolactone) scaffolds function with simvastatin-loaded poly(lactic-co-glycolic acid) microspheres to repair load-bearing segmental bone defects. |
| Q92841042 | Control-released Alpha-lipoic acid-loaded PLGA microspheres enhance bone formation in type 2 diabetic rat model |
| Q52372755 | Neuroprotective strategies for retinal disease. |
| Q47364210 | Phenotypic characterization of P23H and S334ter rhodopsin transgenic rat models of inherited retinal degeneration |
| Q57109454 | Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in Mice |
| Q93003986 | Retinal Cell Protection in Ocular Excitotoxicity Diseases. Possible Alternatives Offered by Microparticulate Drug Delivery Systems and Future Prospects |
| Q55709318 | Retinal Vascular Degeneration in the Transgenic P23H Rat Model of Retinitis Pigmentosa. |
| Q45873271 | The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy |
Search more.